Altogether, these findings indicate that our in vitro observations are likely of pathophysiologic importance for the development of solid tumors, particularly in colon and breast cancer, where the inverse relationship between CXCR4 versus DR5 could be a critical indicator for predicting paclitaxel therapy response as well as the aggressiveness of the particular cancer. This evidence concerns the gene TNFRSF10B and breast carcinoma.